Cross-sectional COVID-19 Surveillance in Several Provinces in Indonesia

It has been almost 3 years of the pandemic, yet l burden of COVID-19 in Indonesia remains fuzzy. The molecular detection of SARS-CoV-2 in Indonesia is predominantly conducted for moderately or severely ill patients, for contact tracing purposes, or as one of the travel requirements. Beyond those needs, the COVID-19 test is massively provided for people to access. Consequently, the high number of ositive cases found through limited tests suggests that the official COVID-19 cases may not represent Indonesia’s burden of SARS-CoV-2 infection.

IThe actual burden of the pandemic will help the government and health authorities design the COVID-19 prevention and control strategies. We may gain the information through a population-based seroprevalence survey. It portrays the extent of SARS-CoV-2 infection in a particular population and the overall population immunity. Furthermore, we may know whether the people’s immunity is achieved from the vaccination or naturally. For that reason, a COVID-19 serosurvey study named Improving Quality of Disease Preparedness, Surveillance & Response in Indonesia (INSPIRASI) will be conducted.

This study selects four provinces with concerning numbers of COVID-19 cases yet never assessed with a population-based COVID-19 survey. The researchers will collect peripheral blood for antibody detection. Later, they will interview the participants to explore the sociodemographic factors, risk factors, knowledge, attitude and practice (KAP) towards COVID-19 and vaccine acceptance.